Morgan Stanley closed $12.79 short of its 52-week high ($136.24), which the company achieved on November 25th.

The performance of Morgan Stanley’s MS trading business (constituting a significant portion of its top line) is expected to ...

Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:GILD) to "overweight" from "equal weight," raising its price target to $113 from $87 on HIV prevention drug Lenacapavir (PrEP) and next-gen HIV ...

Wall Street’s largest investment banks are looking to award traders and dealmakers with their largest bonus increases since the pandemic, with ...

Global equity issuance rose 20% last year, but stock market launches have so far lagged that increase, remaining far below ...

Andrew Forrest has taken a ‘bring it on’ stance in response to ExxonMobil’s defamation lawsuit, which it has filed against ...

The Goldman Sachs Group, Inc. GS is scheduled to release fourth-quarter 2024 earnings on Jan. 15 before the opening bell. Goldman’s close peer JP Morgan JPM is slated to announce quarterly numbers on ...

Morgan Stanley (NYSE: MS) is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offices in 42 ...

(Reuters) - Top Wall-Street brokerages revised their Fed rate cut forecasts, after a blow-out U.S. jobs report on Friday, ...

Major U.S. companies with high-grade credit ratings rushed to issue bonds this week at a dizzying pace, as they moved to get ahead of the spike in Treasury yields that has been making borrowing more ...

BlackRock's pro-risk stance in early 2025 would favor an overweight to equities in a traditional portfolio comprising 60% stocks and 40% bonds, said Kristy Akullian, the giant asset manager's head of ...

S&P 500, Boeing Co, Chevron Corp, Citigroup Inc. Read Investing.com (Jesse Cohen)'s latest article on Investing.com ...